Explore evidence

3.64 ng/mLThe mean serum AMH level in women with HbSS was 3.64 ng/mL.

Nigeriadrépanocytosepublished 2021Journal of ovarian researchPubMeddocument of 4 observations

10.5 hoursThe median length of stay for children with sickle cell disease managed by short-term emergency department observation care was 10.5 hours.

Nigeriadrépanocytoseobserved July 2017 to June 2019published 2020Transactions of the Royal Society of Tropical Medicine and HygienePubMeddocument of 6 observations

0.61 µg/LThe mean ADAMTS13 level in VOC state was 0.61 ± 0.10 µg/L.

Nigeriadrépanocytosepublished 2025Annals of African medicinePubMeddocument of 12 observations

2 %Sickle cell disease impacts 2% of newborns in Nigeria and Ghana.

Ghana · Nigeriadrépanocytosepublished 2021Journal of immigrant and minority healthPubMed

7.2 yearsMost neurological events occurred between 5 and 10 years of age, with a mean onset of 7.2 ± 3.8 years.

Nigeriadrépanocytoseobserved March 2022 and February 2025PubMeddocument of 8 observations

0.7 mg/dLThe mean serum urea among SCA patients was 0.7 ± 0.3 mg/dL.

Nigeriadrépanocytosepublished 2023Malawi medical journal : the journal of Medical Association of MalawiPubMeddocument of 12 observations

23.2 %The prevalence of myocardial ischemia measuring cardiac troponin T alone in children with sickle cell anemia in steady state was 23.2%.

Nigeriadrépanocytose · myocardial ischemiaobserved 2019published 2024Journal of tropical pediatricsPubMeddocument of 6 observations

21.1 %The risk of prolonged QTc interval was 21.1% during steady-state in children with sickle cell anemia.

Nigeriadrépanocytosepublished 2021HemoglobinPubMeddocument of 5 observations

73.6 %Stuttering priapism accounted for 73.6% of the priapism episodes in men with sickle cell disease.

Nigeriadrépanocytosepublished 2020Blood advancesPubMeddocument of 5 observations

48 patientsAmong the 257 enrolled sickle cell anaemia patients, 48 had nonproteinuric chronic kidney disease.

Nigeriadrépanocytose · nonproteinuric chronic kidney diseaseobserved January 2013 to April 2018published 2021Hematology/oncology and stem cell therapyPubMeddocument of 6 observations

2 subjectsGlobin analysis in 30 SCA subjects showed that two had two alpha-globin genes.

Nigeriadrépanocytosepublished 1989African journal of medicine and medical scienceseurope_pmcdocument of 6 observations

75 %Ischaemic ECG identified SCA children with elevated cTnT during VOC with sensitivity 75% and specificity 33.3%.

Nigeriadrépanocytosepublished 2020Paediatrics and international child healtheurope_pmcdocument of 8 observations

12 %Sickle Cell Disease represents an urgent health burden in sub-Saharan Africa, with an estimated mortality of 8-16% in children under 5 years.

Nigeriadrépanocytosepublished 2018Journal of tropical diseases & public healtheurope_pmc

50 %Half of physicians stated hydroxyurea is the standard of care for sickle cell disease in Nigeria.

Nigeriadrépanocytosepublished 2021Frontiers in geneticseurope_pmcdocument of 3 observationsDOI 10.3389/fgene.2021.765958

0 patientsNone of the 85 sickle cell disease patients in a Nigerian hospital were on crinzalizumab.

NigeriadrépanocytosePubMeddocument of 10 observations

35.3 %35.3% of the SCA patients had moderate disease.

Nigeriadrépanocytosepublished 2023Malawi medical journal : the journal of Medical Association of MalawiPubMeddocument of 12 observations

21.4 %The prevalence of cholelithiasis was 21.4% in adolescents with sickle cell disease and 6.5% in younger children with sickle cell disease.

Nigeriacholelithiasis · drépanocytosepublished 2022Annals of African medicinePubMeddocument of 6 observations

98.5 %98.5% of study participants had good knowledge of the best place to get help during sickle cell disease crisis.

Nigeriadrépanocytosepublished 2023Frontiers in geneticseurope_pmcdocument of 5 observationsDOI 10.3389/fgene.2023.1052444

8.5 odds_ratioThe odds of being folate deficient was 8.5 times more likely during anaemic crisis than in vaso-occlusive crisis.

Nigeriadrépanocytoseobserved between September 2018 and March 2019published 2021African health sciencesPubMeddocument of 3 observations

17.2 odds_ratioElevated plasma homocysteine (HHcy) was significantly associated with disease severity among HbSS subjects with odds ratio 17.2.

Nigeriadrépanocytosepublished 2022West African journal of medicinePubMeddocument of 5 observations

0.041 p-valueA significantly higher proportion of the cases than the controls had ST elevation or depression (p = 0.041).

Nigeriadrépanocytosepublished 2023Ghana medical journalPubMeddocument of 7 observations

7,767 patients7,767 people living with sickle cell disease were enrolled at 25 health institutions across the six zones in Nigeria.

Nigeriadrépanocytosepublished 2022Frontiers in geneticseurope_pmcdocument of 8 observations

18 yearsThe median age of the sickle cell disease patients was 18 years.

Nigeriadrépanocytosepublished 2025Nigerian journal of clinical practicePubMeddocument of 5 observations

24.6 %Wasting was observed in 24.6% of subjects with sickle cell anemia.

Nigeriadrépanocytose · malnutritionpublished 2020Nigerian journal of clinical practicePubMeddocument of 9 observations

39.2 %The prevalence of Homozygous S without alpha gene deletion (HbSS) was 39.2% among sickle cell disease patients.

Nigeriadrépanocytosepublished 2022Mediterranean journal of hematology and infectious diseaseseurope_pmcdocument of 17 observationsDOI 10.4084/mjhid.2022.001